152 related articles for article (PubMed ID: 10492365)
21. Increased FDG bone marrow uptake after intracoronary progenitor cell therapy.
Döbert N; Menzel C; Diehl M; Hamscho N; Zaplatnikov K; Grünwald F
Nuklearmedizin; 2005 Feb; 44(1):15-9. PubMed ID: 15711724
[TBL] [Abstract][Full Text] [Related]
22. 18F-FDG PET/CT Imaging of G-CSF-Producing Dedifferentiated Liposarcoma.
Eizuru Y; Nakajo M; Nakajo M; Shinohara N; Yoshiura T
Clin Nucl Med; 2022 Jan; 47(1):e98-e100. PubMed ID: 34183499
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of diffusely increased splenic uptake on FDG-PET.
Liu Y
Nucl Med Commun; 2009 Oct; 30(10):763-9. PubMed ID: 19654562
[TBL] [Abstract][Full Text] [Related]
24. Interaction of colony-stimulating factors and fluorodeoxyglucose f(18) positron emission tomography.
Mayer D; Bednarczyk EM
Ann Pharmacother; 2002 Nov; 36(11):1796-9. PubMed ID: 12398579
[TBL] [Abstract][Full Text] [Related]
25. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG.
Cook GJ; Houston S; Barrington SF; Fogelman I
J Nucl Med; 1998 Jan; 39(1):99-103. PubMed ID: 9443745
[TBL] [Abstract][Full Text] [Related]
26. Association Between Time Since Administration of Pegylated G-CSF (Pegfilgrastim) and Bone Marrow Uptake on FDG PET/CT: Determination of a Minimum Interval.
Minamimoto R; Baratto L; Iagaru A
AJR Am J Roentgenol; 2022 Feb; 218(2):351-358. PubMed ID: 34467784
[No Abstract] [Full Text] [Related]
27. Imaging findings of granulocyte colony-stimulating factor-producing tumors: a case series and review of the literature.
Kohno S; Furuta A; Arizono S; Tokunaga K; Nakao S; Tanabe M; Kataoka TR; Isoda H; Togashi K
Jpn J Radiol; 2021 Sep; 39(9):857-867. PubMed ID: 34021462
[TBL] [Abstract][Full Text] [Related]
28. [A case of lung cancer producing granulocyte colony-stimulating factor with a significantly high uptake in the bones observed by a FDG-PET scan].
Hidaka D; Koshizuka H; Hiyama J; Nakatsubo S; Ikeda K; Hayashi A; Fujii A; Sawamoto R; Misumi Y; Miyagawa Y
Nihon Kokyuki Gakkai Zasshi; 2009 Mar; 47(3):259-63. PubMed ID: 19348277
[TBL] [Abstract][Full Text] [Related]
29. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.
Zasadny KR; Wahl RL
Radiology; 1993 Dec; 189(3):847-50. PubMed ID: 8234714
[TBL] [Abstract][Full Text] [Related]
30. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
31. FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels.
Van de Wiele C; VandeVyver F; Debruyne C; Philippé J; van Meerbeeck JP
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):519-22. PubMed ID: 18034241
[TBL] [Abstract][Full Text] [Related]
32. Disseminated focal
Horvath L; Seeber A; Uprimny C; Wolf D; Nachbaur D; Kocher F
Ther Adv Hematol; 2020; 11():2040620720977613. PubMed ID: 33425313
[TBL] [Abstract][Full Text] [Related]
33. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
34. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial.
Shyu WC; Lin SZ; Lee CC; Liu DD; Li H
CMAJ; 2006 Mar; 174(7):927-33. PubMed ID: 16517764
[TBL] [Abstract][Full Text] [Related]
35. Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images.
Imran MB; Kubota K; Yamada S; Fukuda H; Yamada K; Fujiwara T; Itoh M
J Nucl Med; 1998 Jul; 39(7):1219-23. PubMed ID: 9669398
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies.
Higashi T; Fisher SJ; Brown RS; Nakada K; Walter GL; Wahl RL
J Nucl Med; 2000 Dec; 41(12):2026-35. PubMed ID: 11138688
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET.
Higashi T; Sakahara H; Torizuka T; Nakamoto Y; Kanamori S; Hiraoka M; Imamura M; Nishimura Y; Tamaki N; Konishi J
J Nucl Med; 1999 Sep; 40(9):1424-33. PubMed ID: 10492360
[TBL] [Abstract][Full Text] [Related]
39. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
Uematsu H; Sadato N; Ohtsubo T; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Takahashi N; Yonekura Y; Tsuda G; Saito H; Hayashi N; Yamamoto K; Ishii Y
J Nucl Med; 1998 Mar; 39(3):453-9. PubMed ID: 9529291
[TBL] [Abstract][Full Text] [Related]
40. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin.
Blodgett TM; Ames JT; Torok FS; McCook BM; Meltzer CC
Clin Nucl Med; 2004 Mar; 29(3):161-3. PubMed ID: 15162984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
